Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series

Francesco Burruano; Luigi Caradonna; Silvia Tortorici

Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series

Francesco Burruano, Luigi Caradonna, Silvia Tortorici

Discipline Chirurgiche, Oncologiche e Stomatologiche

Risultato della ricerca: Article › peer review

Abstract

Bisphosphonates are bone-turnover modulating drugs used to treat various diseases such as certain cancers, bone metastasis, bone- and calcium-related disorders, Paget`s disease, osteoporosis and osteopenia. Recently, several preliminary reports have reported the insurgence of osteonecrosis of the mandible and/or maxilla, associated with intravenously administered bisphosphonates. This case series describes the effects of bisphosphonates used in the treatment of certain cancers on oral bone tissues.

Lingua originale	English
pagine (da-a)	925-929
Rivista	RESEARCH JOURNAL OF BIOLOGICAL SCIENCES
Volume	3(8)
Stato di pubblicazione	Published - 2008

Accesso al documento

OA Link

Fingerprint Entra nei temi di ricerca di 'Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series'. Insieme formano una fingerprint unica.

Cita questo

@article{5d465f17a5fe4093ac87a8a0b076630c,

title = "Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series",

abstract = "Bisphosphonates are bone-turnover modulating drugs used to treat various diseases such as certain cancers, bone metastasis, bone- and calcium-related disorders, Paget`s disease, osteoporosis and osteopenia. Recently, several preliminary reports have reported the insurgence of osteonecrosis of the mandible and/or maxilla, associated with intravenously administered bisphosphonates. This case series describes the effects of bisphosphonates used in the treatment of certain cancers on oral bone tissues.",

keywords = "Bisphosphonates, avascular necrosis of the jaw, bone necrosis, cancer, case series, Bisphosphonates, avascular necrosis of the jaw, bone necrosis, cancer, case series",

author = "Francesco Burruano and Luigi Caradonna and Silvia Tortorici",

year = "2008",

language = "English",

volume = "3(8)",

pages = "925--929",

journal = "RESEARCH JOURNAL OF BIOLOGICAL SCIENCES",

issn = "1815-8846",

}

TY - JOUR

T1 - Maxillary bone necrosis following the use of bisphosphonates in patients with cancer: management and case series

AU - Burruano, Francesco

AU - Caradonna, Luigi

AU - Tortorici, Silvia

PY - 2008

Y1 - 2008

N2 - Bisphosphonates are bone-turnover modulating drugs used to treat various diseases such as certain cancers, bone metastasis, bone- and calcium-related disorders, Paget`s disease, osteoporosis and osteopenia. Recently, several preliminary reports have reported the insurgence of osteonecrosis of the mandible and/or maxilla, associated with intravenously administered bisphosphonates. This case series describes the effects of bisphosphonates used in the treatment of certain cancers on oral bone tissues.

AB - Bisphosphonates are bone-turnover modulating drugs used to treat various diseases such as certain cancers, bone metastasis, bone- and calcium-related disorders, Paget`s disease, osteoporosis and osteopenia. Recently, several preliminary reports have reported the insurgence of osteonecrosis of the mandible and/or maxilla, associated with intravenously administered bisphosphonates. This case series describes the effects of bisphosphonates used in the treatment of certain cancers on oral bone tissues.

KW - Bisphosphonates

KW - avascular necrosis of the jaw

KW - bone necrosis

KW - cancer

KW - case series

KW - Bisphosphonates

KW - avascular necrosis of the jaw

KW - bone necrosis

KW - cancer

KW - case series

UR - http://hdl.handle.net/10447/14408

M3 - Article

VL - 3(8)

SP - 925

EP - 929

JO - RESEARCH JOURNAL OF BIOLOGICAL SCIENCES

JF - RESEARCH JOURNAL OF BIOLOGICAL SCIENCES

SN - 1815-8846

ER -